Remove ready-for-resilience-the-supply-chain-future
article thumbnail

Ready for Resilience: The Supply Chain Future

Pharmaceutical Commerce

Maria Whitman and Anshul Agarwal of ZS offer their perspectives on the current and future supply chain challenges facing the global biopharma industry.

52
article thumbnail

Pharma manufacturing can digitalise its way round the next crisis

pharmaphorum

Crisis readiness and digital workflows. Digital workflows also facilitate collaboration along the product lifecycle, enabling data-driven decision making and improving inspection readiness. The turbulence of the last three years can make it seem as though pharma manufacturers have been operating in an atmosphere of non-stop crisis.

Vaccines 107
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

How resilient is the global biopharma industry?

Pharmaceutical Technology

The need for the sector to rapidly research, develop and test new vaccines had always been of critical importance, but in the context of a global pandemic and national lockdowns, it became even more so, with each part of the supply chain required to face up to the full weight of the task. Let’s examine the key findings.

article thumbnail

Build back better: US pharma and the future of healthcare

pharmaphorum

America’s biopharmaceutical industry says it is “ready to do its part” in building a stronger, more resilient, affordable, and equitable health care system for all. That means learning the lessons of the last 18 months, by enhancing supply chain capacity and investing in pandemic preparedness and planning, said the report.

Insurance 105
article thumbnail

Preparing for a post-pandemic world

pharmaphorum

That’s how we plan, and how we prepare ourselves for a stronger, more resilient future. Supply chains flexed and adapted to get essential goods where they needed to be. The key now is to carry this mindset forward, so we prepare ourselves not just for the next worldwide threat, but for whatever the future holds.

article thumbnail

A Member’s Guide to the 2023 ISPE Annual Meeting & Expo

ISPE

From Digital Transformation, Manufacturing, Quality Control & Operational Excellence, to Regulatory, Compliance & Quality, Supply Chain Resiliency, and Advanced Therapy & Manufacturing, our conference covers all the essential aspects. And this is just a sneak peek! And this is just a sneak peek!

52
article thumbnail

Post-Brexit medicines regulation must have international scope

pharmaphorum

The COVID-19 pandemic, Goldrick said, had demonstrated what friction could do to global supply chains. Post-pandemic, post-Brexit Britain must create a regulatory framework that both defines and aligns with international standards, or risk being left behind. Opportunities and pitfalls.